COO Down 13% in One Day: Is It Outperforming Its Rivals?
Here is how Cooper Companies (COO) stacks up against its peers in size, valuation, growth and margin.
- COO’s operating margin of 19.0% is strong, lower than most peers – trailing REGN (27.0%).
- COO’s revenue growth of 6.9% in the last 12 months is moderate, outpacing JNJ, REGN, STAA, WST but lagging BSX.
- COO’s stock is down 31.7% in last 1 year, and trades at a PE of 31.2; it underperformed JNJ, BSX, STAA, WST.
As a quick background, Cooper Companies provides medical devices, fertility, genomics, diagnostics, and vision-correcting lenses addressing various eye conditions to healthcare professionals and patients.
| COO | JNJ | BSX | REGN | STAA | WST | |
|---|---|---|---|---|---|---|
| Market Cap ($ Bil) | 12.9 | 422.2 | 156.5 | 60.9 | 1.4 | 17.7 |
| Revenue ($ Bil) | 4.0 | 90.6 | 18.5 | 14.2 | 0.2 | 3.0 |
| PE Ratio | 31.2 | 18.6 | 62.5 | 13.7 | -14.2 | 36.3 |
| LTM Revenue Growth | 6.9% | 4.7% | 21.4% | 5.4% | -32.6% | 2.9% |
| LTM Operating Margin | 19.0% | 24.5% | 18.3% | 27.0% | -36.4% | 21.0% |
| LTM FCF Margin | 9.2% | 18.1% | 17.5% | 25.0% | -19.5% | 11.6% |
| 12M Market Return | -31.7% | 10.5% | 33.0% | -51.5% | -14.1% | -17.3% |
Why does this matter? COO just went down -12.9% in a day – peer comparison puts stock performance, valuation, and financials in context – highlighting whether it is truly outperforming, lagging behind, and above all – can this continue? Read Buy or Sell COO Stock to see if Cooper Companies is really a falling knife. Sharp dips often come with rebound opportunities – see how the stock has dipped and recovered in the past through COO Dip Buyer Analysis lens.
While peer comparison is critical Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risks while giving upside exposure.
Revenue Growth Comparison
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| COO | 6.9% | 8.4% | 8.6% | 13.2% |
| JNJ | 4.7% | 4.3% | 6.5% | 1.6% |
| BSX | 21.4% | 17.6% | 12.3% | 6.7% |
| REGN | 5.4% | 8.3% | 7.8% | -24.3% |
| STAA | -32.6% | -2.6% | 13.4% | 23.4% |
| WST | 2.9% | -1.9% | 2.2% | 2.0% |
Operating Margin Comparison
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| COO | 19.0% | 18.1% | 14.8% | 15.3% |
| JNJ | 24.5% | 24.9% | 27.5% | 26.3% |
| BSX | 18.3% | 17.9% | 17.0% | 16.0% |
| REGN | 27.0% | 28.1% | 30.9% | 38.9% |
| STAA | -36.4% | -4.0% | 8.7% | 15.4% |
| WST | 21.0% | 20.4% | 24.0% | 26.4% |
PE Ratio Comparison
| LTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| COO | 31.2 | 46.6 | 63.6 | 42.3 |
| JNJ | 18.6 | 24.8 | 11.3 | 25.8 |
| BSX | 62.5 | 70.9 | 52.7 | 94.8 |
| REGN | 13.7 | 17.4 | 23.7 | 17.8 |
| STAA | -14.2 | -59.0 | 70.9 | 58.7 |
| WST | 36.3 | 48.5 | 44.1 | 29.9 |
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.